hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06352047, orgStudyIdInfo id: Karadeniz Tech. University, briefTitle: The Effects of Positioning After Extubation of Preterm Infants on the Respiratory Functions, statusModule overallStatus: COMPLETED, startDateStruct date: 2018-11-01, primaryCompletionDateStruct date: 2019-06-01, completionDateStruct date: 2019-06-01, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Karadeniz Technical University, class: OTHER, descriptionModule briefSummary: The aim of this study was to examine the effect of positioning on respiratory functions of preterm infants after extubation.Hypothesis 0a (H0a): There is no difference between the oxygen saturation (SpO2) levels of preterm infants in supine and prone positions after extubation.Hypothesis 0b (H0b): There is no difference between the respiratory rate of preterm infants in supine and prone positions after extubation.Hypothesis 0c (H0c): There is no difference between the respiratory rhythms of preterm infants in supine and prone positions after extubation.Hypothesis 0d (H0d): There is no difference between respiratory distress in preterm infants in supine and prone positions after extubation., conditionsModule conditions: Premature Infants, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Simple randomization method was used in the sample of the study. In previous studies, there were no published data on the effect of supine and prone positioning after extubation on the pulmonary functions of premature infants. Therefore, the sample size was calculated using the G-power 3.1.3 program according to the SpO2 level and standard deviation values of 4 infants who were mechanically ventilated in the neonatal intensive care unit. The study was conducted with a total of 42 premature babies, two groups of 21 premature babies, each of whom had the characteristics of the research groups. Premature infants were divided into two groups, the supine position and the prone group, by randomization using a computer-based random number generator (www.randomizer.org)., primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: DOUBLE, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 42, type: ACTUAL, armsInterventionsModule interventions name: The effect of positioning on respiratory functions of preterm infants after extubation., outcomesModule primaryOutcomes measure: Newborn Evaluation Form, eligibilityModule sex: ALL, minimumAge: 37 Weeks, maximumAge: 37 Weeks, stdAges: CHILD, contactsLocationsModule locations facility: İlknur Kahriman, city: Trabzon, zip: 61080, country: Turkey, geoPoint lat: 41.005, lon: 39.72694, locations facility: Karadeniz Technical University Health Application and Research Center Farabi Hospital, city: Trabzon, zip: 61080, country: Turkey, geoPoint lat: 41.005, lon: 39.72694, hasResults: False
protocolSection identificationModule nctId: NCT06352034, orgStudyIdInfo id: Empathy Training for Students, briefTitle: Empathy Training for Future Mental Health Practitioners in University Students, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-30, primaryCompletionDateStruct date: 2024-04-30, completionDateStruct date: 2024-10-01, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Peking University, class: OTHER, descriptionModule briefSummary: This study aims to investigate the efficacy of empathy training for future psychological counselors in university students. The training contains 5 sessions of psychoeducation, three-role group exercises, and Q\&A. Self-reported, listener-reported, and observer-reported measurements will be applied for empathy assessment., conditionsModule conditions: Empathy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 50, type: ESTIMATED, armsInterventionsModule interventions name: Empathy Training, outcomesModule primaryOutcomes measure: Change from counseling duration, primaryOutcomes measure: Change from Baseline of 12-Item Version of the Barrett-Lennard Relationship Inventory, primaryOutcomes measure: Change from consultation willingness question inquiry, primaryOutcomes measure: Change from morphed emotion perception task, primaryOutcomes measure: Change from Baseline of the Measure of Empathy Scale, primaryOutcomes measure: Change from Baseline of the Emotion Perception Scale, primaryOutcomes measure: Change from Baseline of the Peking Alexithymia Scale, secondaryOutcomes measure: Change from Baseline of the Patient Health Questionnaire, secondaryOutcomes measure: Change from Baseline of the Generalized Anxiety Disorder Scale, secondaryOutcomes measure: Change from Baseline of the Peking Irritability Scale, secondaryOutcomes measure: Change from Baseline of the the Fatigue Assessment Scale, secondaryOutcomes measure: Change from Baseline of the the Patient Health Questionnaire, secondaryOutcomes measure: Change from Baseline of the Cognitive-Emotion Regulation Questionnaire, secondaryOutcomes measure: Change from Baseline of the Difficulties in Emotion Regulation Scale, secondaryOutcomes measure: Change from Baseline of the the Satisfaction with Life Scale, secondaryOutcomes measure: Change from Baseline of the the Subjective Happiness Scale, secondaryOutcomes measure: Change from Baseline of the Connor-Davidson Resilience Scale, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Peking University, city: Peking, state: Beijing, zip: 100871, country: China, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06352021, orgStudyIdInfo id: KAHRİMAN İlknur, briefTitle: The Effect of Distraction With a Kaleidoscope on the Level of Perceived Pain During Blood Sampling in Children, statusModule overallStatus: COMPLETED, startDateStruct date: 2019-05-30, primaryCompletionDateStruct date: 2019-06-30, completionDateStruct date: 2019-06-30, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: İlknur KAHRİMAN, class: OTHER, descriptionModule briefSummary: This experimental study aimed to determine the effect of distracting children with a kaleidoscope during blood sampling on their perception of pain during the procedure and to increase and improve the quality of evidence for the effectiveness of these methods across different populations and cultures.Hypothesis 0 (H0): There is no difference between the pain scores of the kaleidoscope group and the control group during blood sampling.Hypothesis 1 (H1): There is a difference between the pain scores of the kaleidoscope group and the control group during blood sampling., conditionsModule conditions: Pain, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: kaleidoscope, outcomesModule primaryOutcomes measure: The Wong-Baker Pain Scale, eligibilityModule sex: ALL, minimumAge: 7 Years, maximumAge: 12 Years, stdAges: CHILD, contactsLocationsModule locations facility: Karadeniz Technical University Health Application and Research Center Farabi Hospital, city: Trabzon, zip: 61080, country: Turkey, geoPoint lat: 41.005, lon: 39.72694, hasResults: False
protocolSection identificationModule nctId: NCT06352008, orgStudyIdInfo id: Zhansheng Jiang, briefTitle: To Evaluate the Efficacy and Safety of Anrotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06-01, primaryCompletionDateStruct date: 2025-06-01, completionDateStruct date: 2026-06-01, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Tianjin Medical University Cancer Institute and Hospital, class: OTHER, descriptionModule briefSummary: To explore the effectiveness of anrotinib hydrochloride capsule in postoperative non-pCR non-small cell lung cancer patients with adjuvant intensive therapy, conditionsModule conditions: Event-free Lifetime, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 64, type: ESTIMATED, armsInterventionsModule interventions name: Anlotinib, outcomesModule primaryOutcomes measure: EFS, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Tianiin Medical University Cancer Institute & Hospital, city: Tianjin, country: China, contacts role: CONTACT, phone: +008618526812877, geoPoint lat: 39.14222, lon: 117.17667, hasResults: False
protocolSection identificationModule nctId: NCT06351995, orgStudyIdInfo id: KOR-19-22, briefTitle: Neostigmine and Glycopyrrolate by Iontophoresis, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2020-11-06, primaryCompletionDateStruct date: 2022-10-25, completionDateStruct date: 2025-01-01, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: James J. Peters Veterans Affairs Medical Center, class: FED, descriptionModule briefSummary: To determine a lower effective dose of neostigmine to induce bowel evacuation by transcutaneous administration by iontophoresis., conditionsModule conditions: Spinal Cord Injuries, conditions: Constipation, conditions: Fecal Incontinence, conditions: Neurogenic Bowel, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 6, type: ACTUAL, armsInterventionsModule interventions name: Combination of Neostigmine and Glycopyrrolate, interventions name: I-Box by Dynatronics, outcomesModule primaryOutcomes measure: Presence or absence of bowel evacuation, primaryOutcomes measure: Time to bowel evacuation, primaryOutcomes measure: Stool Consistency, primaryOutcomes measure: Stool Quantity, secondaryOutcomes measure: Presence or absence of headache, dry mouth, muscle twitching and abdominal cramps., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 89 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: James J. Peters Veterans Affairs Medical Center, city: Bronx, state: New York, zip: 10468, country: United States, geoPoint lat: 40.84985, lon: -73.86641, hasResults: False
protocolSection identificationModule nctId: NCT06351969, orgStudyIdInfo id: Ms 9-12-2023, briefTitle: Evaluating Placental Thickness and Thickness of Uterine Muscle at Placenta Attachment in Prediction of Postpartum Blood Loss, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-12-21, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Benha University, class: OTHER, descriptionModule briefSummary: Aim of the Work is To determine the significance of the placental thickness and the thickness of the uterine muscle layer at placenta attachment in the prediction of postpartum hemorrhage and to evaluate both of them as as parameters for identifying high-risk patients., conditionsModule conditions: Post Partum Hemorrhage, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 150, type: ESTIMATED, outcomesModule primaryOutcomes measure: Evaluating Placental Thickness in cm and Thickness of Uterine Muscle in cm at Placenta Attachment in Prediction of Postpartum Blood Loss, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: Benha Univeristy, status: RECRUITING, city: Banhā, country: Egypt, contacts name: Ashraf Ismail mohamed, professor, role: CONTACT, phone: +201119709696, geoPoint lat: 30.45906, lon: 31.17858, hasResults: False
protocolSection identificationModule nctId: NCT06351956, orgStudyIdInfo id: Arrhythmias in Septic Patients, briefTitle: New Onset Cardiac Arrhythmias in Septic Patients in Critical Care Setting, Predictors and Outcomes., statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-20, primaryCompletionDateStruct date: 2026-04-20, completionDateStruct date: 2026-12-30, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: New Onset Cardiac Arrhythmias in Septic Patients in Critical Care Setting, Predictors and Outcomes, conditionsModule conditions: Cardiac Arrhythmia, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 72, type: ESTIMATED, outcomesModule primaryOutcomes measure: Risk Factors of cardiac arrhythmias in septic patients in CU., primaryOutcomes measure: Fates of cardiac arrhythmia., secondaryOutcomes measure: The frequent type of arrhythmias., secondaryOutcomes measure: Mortality rate due to new onset arrhythmia., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06351943, orgStudyIdInfo id: ImageDB pilot, briefTitle: Proximal Femur Image Database Validation, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2021-05-01, primaryCompletionDateStruct date: 2024-10-01, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: AO Innovation Translation Center, class: OTHER, collaborators name: University of Turin, Italy, descriptionModule briefSummary: The AO@AI Turin project is a collaborative project with a Turin group and the AO (Arbeitsgemeinschaft für Osteosynthesefragen, or in English, Association for the Study of Internal Fixation) foundation. An Image database (DB) has been built to host AP pelvic radiographs ready for artificial intelligence (AI) development.The goal of this project is to determine the agreement between the Turin annotation of fracture status and the annotation from an external group of AO expert surgeons for a random subset of the Turin images., conditionsModule conditions: Proximal Femoral Fracture, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 2932, type: ESTIMATED, armsInterventionsModule interventions name: Fracture classification annotations provided by the Turin group, interventions name: Fracture classification annotations provided by the AO expert surgeon group, outcomesModule primaryOutcomes measure: Annotations of fracture status of the image, primaryOutcomes measure: In case of fracture, Arbeitsgemeinschaft für Osteosynthesefragen (AO, in English, Association for the Study of Internal Fixation)/Orthopedic Trauma Association (OTA) classification: Type, primaryOutcomes measure: In case of fracture, AO/OTA classification: Group, primaryOutcomes measure: In case of fracture, AO/OTA classification: Subgroup, primaryOutcomes measure: In case of fracture, AO/OTA classification: Qualifier for 31A1.1, primaryOutcomes measure: In case of fracture, AO/OTA classification: Qualifier for 31B2, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: AO Foundation, city: Dübendorf, zip: 8600, country: Switzerland, geoPoint lat: 47.39721, lon: 8.61871, hasResults: False
protocolSection identificationModule nctId: NCT06351917, orgStudyIdInfo id: LEVEXE, briefTitle: Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2025-04-01, completionDateStruct date: 2025-05-01, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: RDC Clinical Pty Ltd, class: INDUSTRY, descriptionModule briefSummary: This is a randomised, double-blind, placebo controlled, 2 arm parallel clinical trial to evaluate the effect of topical PlexoZome® Levagen® spray on relief of post exercise knee joint pain in healthy adults compared to placebo over 4 weeks duration., conditionsModule conditions: Knee Joint Pain, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: PlexoZome® Levagen® topical spray solution, interventions name: Placebo topical spray solution, outcomesModule primaryOutcomes measure: Joint pain, secondaryOutcomes measure: Time to pain relief, secondaryOutcomes measure: Number of Adverse Events, secondaryOutcomes measure: Severity of Adverse Events, secondaryOutcomes measure: Rescue medication use, eligibilityModule sex: ALL, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: RDC Clinical Pty Ltd, city: Brisbane, state: Queensland, zip: 4006, country: Australia, contacts name: Amanda Rao, PhD, role: CONTACT, phone: +61 414 488 559, email: amanda@rdcglobal.com.au, contacts name: David Briskey, PhD, role: CONTACT, phone: +61 421 784 077, email: david@rdcglobal.com.au, contacts name: Amanda Rao, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: -27.46794, lon: 153.02809, hasResults: False
protocolSection identificationModule nctId: NCT06351904, orgStudyIdInfo id: RAG-01-01, briefTitle: A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-03, primaryCompletionDateStruct date: 2025-06-30, completionDateStruct date: 2025-08-31, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: Ractigen Therapeutics., class: OTHER, descriptionModule briefSummary: This is an open label, multi-center study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of RAG-01 in patients with NMIBC who have failed BCG therapy., conditionsModule conditions: Non-Muscle-Invasive Bladder Cancer (NMIBC), designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 15, type: ESTIMATED, armsInterventionsModule interventions name: RAG-01, outcomesModule primaryOutcomes measure: Safety and tolerability of RAG-01 in patients with non-muscle-invasive bladder cancer (NMIBC), primaryOutcomes measure: Maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D) of RAG-01, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: GenesisCare North Shore, status: RECRUITING, city: St Leonards, state: New South Wales, zip: 2065, country: Australia, contacts name: Laurence Krieger, MBCHB, role: CONTACT, phone: +61 2 8037 4100, email: laurence_krieger@hotmail.com, geoPoint lat: -33.82344, lon: 151.19836, hasResults: False
protocolSection identificationModule nctId: NCT06351891, orgStudyIdInfo id: SHARE2402, briefTitle: Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Qilu Hospital of Shandong University, class: OTHER, descriptionModule briefSummary: The researchers collected untreated H. pylori positive patients from outpatient clinics. Subjects were randomly assigned to receive either 14 days of bismuth quadruple therapy with cefuroxime and tetracycline or 14 days of bismuth quadruple therapy with cefuroxime and levofloxacin for Helicobacter pylori eradication. After 6 weeks of treatment, subjects underwent another 13C urea breath test. Eradication rates, adverse reaction rates and patient compliance were calculated., conditionsModule conditions: Helicobacter Pylori Infection, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 248, type: ESTIMATED, armsInterventionsModule interventions name: 14-day bismuth quadruple regimen containing cefuroxime and tetracycline, interventions name: 14-day bismuth quadruple regimen containing cefuroxime and levofloxacin, outcomesModule primaryOutcomes measure: Eradication rate, secondaryOutcomes measure: Rate of adverse reactions, secondaryOutcomes measure: Patient compliance, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Qilu Hospital of Shandong University, city: Jinan, state: Shandong, zip: 250012, country: China, contacts name: Yueyue Li, MD,PhD, role: CONTACT, phone: 86-18560089751, email: lyynqj@162.com, geoPoint lat: 36.66833, lon: 116.99722, hasResults: False
protocolSection identificationModule nctId: NCT06351878, orgStudyIdInfo id: Pro00113559, briefTitle: TipTraQ Home Sleep Test Validation Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-28, primaryCompletionDateStruct date: 2024-08-23, completionDateStruct date: 2024-08-23, studyFirstPostDateStruct date: 2024-04-08, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: PranaQ Pte. Ltd., class: INDUSTRY, descriptionModule briefSummary: A validation study has been designed to assess the performance of a home sleep test device, TipTraQ, for screening sleep apnea. The study involves participants wearing the TipTraQ device on their fingertip during a traditional sleep test, known as polysomnography (PSG), conducted in a sleep center. The performance of the device will then be evaluated by comparing the results from the TipTraQ system with those from the traditional sleep test., conditionsModule conditions: Obstructive Sleep Apnea, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 125, type: ESTIMATED, outcomesModule primaryOutcomes measure: Apnea Hypopnea Index(AHI), primaryOutcomes measure: Oxygen Desaturation Index(ODI), primaryOutcomes measure: Total Sleep Time(TST), eligibilityModule sex: ALL, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Duke University, status: RECRUITING, city: Durham, state: North Carolina, zip: 27705, country: United States, contacts name: Alexis Schuettke, role: CONTACT, phone: 919-668-2842, email: alexis.schuettke@duke.edu, geoPoint lat: 35.99403, lon: -78.89862, hasResults: False